Jonathan Zalevsky Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jonathan Zalevsky.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jonathan Zalevsky. Jonathan Zalevsky is Chief R&D Officer in NEKTAR THERAPEUTICS ($NKTR).
Latest Insider Trading Transactions of Jonathan Zalevsky
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2021 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Sell | S | 22.37 | 24,141 | 540,034 | 266,176 | 290.3 K to 266.2 K (-8.32 %) |
| Dec 22 2020 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Option Exercise | A | 18.75 | 71,500 | 1,340,625 | 71,500 | |
| Dec 22 2020 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Grant | A | 0.00 | 40,000 | 0 | 290,317 | 250.3 K to 290.3 K (+15.98 %) |
| Nov 25 2020 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Sell | S | 16.40 | 16,380 | 268,632 | 250,317 | 266.7 K to 250.3 K (-6.14 %) |
| Aug 19 2020 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Sell | S | 19.67 | 26,200 | 515,354 | 296,315 | 322.5 K to 296.3 K (-8.12 %) |
| May 20 2020 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Sell | S | 22.51 | 4,558 | 102,601 | 322,515 | 327.1 K to 322.5 K (-1.39 %) |
| Feb 20 2020 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Sell | S | 22.35 | 4,774 | 106,699 | 327,073 | 331.8 K to 327.1 K (-1.44 %) |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Option Exercise | A | 21.79 | 20,100 | 437,979 | 20,100 | |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Option Exercise | A | 21.79 | 71,550 | 1,559,075 | 71,550 | |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Grant | A | 0.00 | 40,150 | 0 | 331,847 | 291.7 K to 331.8 K (+13.76 %) |
| Nov 20 2019 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Sell | S | 17.97 | 3,960 | 71,161 | 291,697 | 295.7 K to 291.7 K (-1.34 %) |
| Oct 02 2019 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Option Exercise | A | 18.43 | 150,000 | 2,764,500 | 150,000 | |
| Oct 02 2019 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Grant | A | 0.00 | 75,000 | 0 | 295,657 | 220.7 K to 295.7 K (+33.99 %) |
Page: 1